ArticleOchsner journal2026
Endometrial Carcinoma Unveiling Breast Carcinoma in a Postmenopausal Female: A Case of Synchronous Malignancy.
Article in Ochsner journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The ability to detect multiple primary malignancies in a single patient has improved because of modern cancer screening and imaging technologies. While both endometrial and breast carcinomas are common in postmenopausal women, concomitant presentation is uncommon. Case Report: A 61-year-old postmenopausal female initially presented with abdominal pain and postmenopausal bleeding. Positron emission tomography/computed tomography revealed fluorodeoxyglucose-avid lesions in the left breast and axilla, although mammography showed Breast Imaging Reporting and Data System category 1. Clinical breast and axillary examinations were unremarkable. Immunohistochemistry demonstrated GATA binding protein 3 and human epidermal growth factor receptor 2 positivity in the axillary lymph nodes, suggestive of breast carcinoma, while positivity for paired box gene 8, estrogen receptors, and progesterone receptors supported an endometrial tumor. Genetic testing panel results were negative. After undergoing neoadjuvant chemotherapy, the patient had marked regression in the endometrial lesion and a pathologic complete response in the breast lesion. Conclusion: Because of the infrequency and clinical complexity associated with synchronous malignancies, this case highlights the importance of a multidisciplinary approach, advanced imaging, and molecular profiling for accurate diagnosis and personalized treatment planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.